Style | Citing Format |
---|---|
MLA | Farokhi M, et al.. "Functionalized Silk Fibroin Nanofibers As Drug Carriers: Advantages and Challenges." Journal of Controlled Release, vol. 321, no. , 2020, pp. 324-347. |
APA | Farokhi M, Mottaghitalab F, Reis RL, Ramakrishna S, Kundu SC (2020). Functionalized Silk Fibroin Nanofibers As Drug Carriers: Advantages and Challenges. Journal of Controlled Release, 321(), 324-347. |
Chicago | Farokhi M, Mottaghitalab F, Reis RL, Ramakrishna S, Kundu SC. "Functionalized Silk Fibroin Nanofibers As Drug Carriers: Advantages and Challenges." Journal of Controlled Release 321, no. (2020): 324-347. |
Harvard | Farokhi M et al. (2020) 'Functionalized Silk Fibroin Nanofibers As Drug Carriers: Advantages and Challenges', Journal of Controlled Release, 321(), pp. 324-347. |
Vancouver | Farokhi M, Mottaghitalab F, Reis RL, Ramakrishna S, Kundu SC. Functionalized Silk Fibroin Nanofibers As Drug Carriers: Advantages and Challenges. Journal of Controlled Release. 2020;321():324-347. |
BibTex | @article{ author = {Farokhi M and Mottaghitalab F and Reis RL and Ramakrishna S and Kundu SC}, title = {Functionalized Silk Fibroin Nanofibers As Drug Carriers: Advantages and Challenges}, journal = {Journal of Controlled Release}, volume = {321}, number = {}, pages = {324-347}, year = {2020} } |
RIS | TY - JOUR AU - Farokhi M AU - Mottaghitalab F AU - Reis RL AU - Ramakrishna S AU - Kundu SC TI - Functionalized Silk Fibroin Nanofibers As Drug Carriers: Advantages and Challenges JO - Journal of Controlled Release VL - 321 IS - SP - 324 EP - 347 PY - 2020 ER - |